da Martina Zanero | Mag 30, 2024 | Press release
We are pleased to announce the first trans-septal clinical trial implant with our proprietary Saturn Transcatheter Mitral Valve. Excellent hemodynamic results are reported for the patient, a 79 year old female suffering from severe mixed (degenerative and functional)...
da Martina Zanero | Mar 30, 2022 | Press release
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
da Martina Zanero | Gen 27, 2022 | Press release
InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China Milan, January 27, 2022 – InnovHeart s.r.l. announces the closing of its Series C financing with...
da Martina Zanero | Gen 12, 2021 | Press release
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation, announced today the appointment of successful serial entrepreneur and medical device executive Dr. Azin Parhizgar, Ph.D. as an...
da Chiara | Set 24, 2020 | Press release
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation (MR), announced today the successful Firstin-Human implantation of its proprietary Saturn Transcatheter Mitral Valve along with...
da Chiara | Ago 7, 2020 | Press release
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 million round of equity financing. Founded in 2015 by Giovanni Righini, a 30-year veteran of...
